| Trade Name |
Aexidal Tablet 50 mg |
| Generic |
Mebhydrolin Napadisylate |
| Weight |
50 mg |
| Type |
Tablet |
| Therapeutic Class |
Sedating Anti-histamine |
| Manufacturer |
Albion Laboratories Limited |
| Available Country |
Bangladesh |
| Last Updated: |
January 7, 2025 at 1:49 am |
Uses
Aexidal Tablet 50 mg is indicated in-
Allergic disease or symptoms such as urticaria
Pruritus of various origin
Eczema
Itching
Drug rash
Insect bites
Allergic conjunctivitis
Dermatitis of nutritional origin
Hay fever,
Vasomotor rhinitis
Allergic asthma.
Dosage
Adults and children over 10 years: 2-6 tablets dailyChildren-
5-10 years: 2-4 tablets daily
2-5 years: 1-3 tablets daily
Up to 2 years: 1-2 tablets daily
Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.
Side Effects
Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.
Precaution
The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.
Interaction
The effects of atropine and tricyclic anti-depressants may be enhanced by Mebhydrolin. It may mask the warning symptoms of damage caused by ototoxic drugs.
Pregnancy & Breastfeeding use
Safety in pregnancy and lactation has not been established.
Contraindication
Hypersensitivity to any of the ingredients of Mebhydrolin tablet or to mebhydrolin
Prostatic hypertrophy, narrow-angle glaucoma.
First trimester of pregnancy.
Special Warning
Safety in pregnancy and lactation has not been established.
Storage Condition
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Innovators Monograph
